Literature DB >> 11170275

Identification of a heparin-binding protein in bovine seminal fluid as tissue inhibitor of metalloproteinases-2.

T C McCauley1, H M Zhang, M E Bellin, R L Ax.   

Abstract

Presence or absence of three distinct bovine seminal heparin-binding proteins (21-31 kDa) recognized in sperm extracts by a monoclonal antibody, M1, is a diagnostic indicator of fertility differences among bulls producing normal semen. We recently identified a 31 kDa fertility-associated antigenin bovine seminal fluid as a unique DNase I-like protein. We now report purification and identification of a 24 kDa seminal heparin-binding protein (HBP-24) recognized by M1. N-terminal microsequence analysis of HBP-24 purified from seminal fluid yielded 20 amino acid residues that displayed 90% identity to the N-terminus of a bovine metalloproteinase inhibitor identified as tissue inhibitor of metalloproteinases-2 (TIMP-2). A single immunoreactive band migrating at 24 kDa was detected in Western blots of cauda epididymal sperm extracts following incubation with purified seminal heparin-binding proteins and subsequent washing in vitro, indicating TIMP-2 bound to sperm membranes. Expression of TIMP-2 mRNA was detected by RT-PCR in bovine bulbourethral gland, prostate, and seminal vesicles. Mobility of the 24 kDa heparin-binding protein increased under nonreducing SDS-PAGE to approximately 21 kDa, characteristic of the reported molecular mass of TIMP-2. To our knowledge, this is the first report of TIMP-2 binding to spermatozoa and of TIMP-2 mRNA expression in bovine accessory sex glands. These results corroborate previous reports regarding the site of production of heparin-binding proteins that are related to bull fertility, and suggest that TIMP-2 influences fertility of bulls, either through inhibition of metalloprotease activity in semen or via undefined activities independent of matrix metalloproteinase (MMP) inhibition. Copyright 2001 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11170275     DOI: 10.1002/1098-2795(200103)58:3<336::AID-MRD12>3.0.CO;2-Z

Source DB:  PubMed          Journal:  Mol Reprod Dev        ISSN: 1040-452X            Impact factor:   2.609


  6 in total

1.  The cysteine-rich domain of the secreted proprotein convertases PC5A and PACE4 functions as a cell surface anchor and interacts with tissue inhibitors of metalloproteinases.

Authors:  Nadia Nour; Gaétan Mayer; John S Mort; Alexandre Salvas; Majambu Mbikay; Charlotte J Morrison; Christopher M Overall; Nabil G Seidah
Journal:  Mol Biol Cell       Date:  2005-08-31       Impact factor: 4.138

2.  Seasonal differences in seminal plasma proteins from two bovine breeds adapted to a subtropical climate.

Authors:  Paula Lorena Souto; Lilian Silveira Travassos Carmouy; Cristiane Santos; Edison Martins; Vera Martins; Luciana Keiko Hatamoto-Zervoudakis; André Melro Murad; Angela Mehta; Concepta McManus; Alexandre Floriano Ramos
Journal:  Trop Anim Health Prod       Date:  2021-01-03       Impact factor: 1.559

3.  Protease Expression Levels in Prostate Cancer Tissue Can Explain Prostate Cancer-Associated Seminal Biomarkers-An Explorative Concept Study.

Authors:  Jochen Neuhaus; Eric Schiffer; Ferdinando Mannello; Lars-Christian Horn; Roman Ganzer; Jens-Uwe Stolzenburg
Journal:  Int J Mol Sci       Date:  2017-05-04       Impact factor: 5.923

4.  Proteomic landscape of seminal plasma associated with dairy bull fertility.

Authors:  A G A Viana; A M A Martins; A H Pontes; W Fontes; M S Castro; C A O Ricart; M V Sousa; A Kaya; E Topper; E Memili; A A Moura
Journal:  Sci Rep       Date:  2018-11-05       Impact factor: 4.379

5.  Protein signatures of seminal plasma from bulls with contrasting frozen-thawed sperm viability.

Authors:  Fabio P Gomes; Robin Park; Arabela G Viana; Carolina Fernandez-Costa; Einko Topper; Abdullah Kaya; Erdogan Memili; John R Yates; Arlindo A Moura
Journal:  Sci Rep       Date:  2020-09-04       Impact factor: 4.379

6.  Gamete therapeutics: recombinant protein adsorption by sperm for increasing fertility via artificial insemination.

Authors:  Horacio Alvarez-Gallardo; Michael E Kjelland; Juan F Moreno; Thomas H Welsh; Ronald D Randel; Miguel A Lammoglia; Mario Pérez-Martínez; Alma V Lara-Sagahón; A Enrique Esperón-Sumano; Salvador Romo
Journal:  PLoS One       Date:  2013-06-10       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.